| Original Research Online Publishing Date: | ||||||||||||
Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center Karthikeyan T M, Veenaa N N, Shivapriya R, Arun Kumar, Umamageswari M S.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style M KT, N VN, R S, Kumar A, S UM. Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. Natl J Physiol Pharm Pharmacol. 2024; 14(3): 473-479. doi:10.5455/njppp.2023.13.08381202316082023 Web Style M KT, N VN, R S, Kumar A, S UM. Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. https://www.njppp.com/?mno=163438 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.08381202316082023 AMA (American Medical Association) Style M KT, N VN, R S, Kumar A, S UM. Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. Natl J Physiol Pharm Pharmacol. 2024; 14(3): 473-479. doi:10.5455/njppp.2023.13.08381202316082023 Vancouver/ICMJE Style M KT, N VN, R S, Kumar A, S UM. Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. Natl J Physiol Pharm Pharmacol. (2024), [cited March 14, 2024]; 14(3): 473-479. doi:10.5455/njppp.2023.13.08381202316082023 Harvard Style M, K. T., N, . V. N., R, . S., Kumar, . A. & S, . U. M. (2024) Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. Natl J Physiol Pharm Pharmacol, 14 (3), 473-479. doi:10.5455/njppp.2023.13.08381202316082023 Turabian Style M, Karthikeyan T, Veenaa N N, Shivapriya R, Arun Kumar, and Umamageswari M S. 2024. Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. National Journal of Physiology, Pharmacy and Pharmacology, 14 (3), 473-479. doi:10.5455/njppp.2023.13.08381202316082023 Chicago Style M, Karthikeyan T, Veenaa N N, Shivapriya R, Arun Kumar, and Umamageswari M S. "Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 473-479. doi:10.5455/njppp.2023.13.08381202316082023 MLA (The Modern Language Association) Style M, Karthikeyan T, Veenaa N N, Shivapriya R, Arun Kumar, and Umamageswari M S. "Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center." National Journal of Physiology, Pharmacy and Pharmacology 14.3 (2024), 473-479. Print. doi:10.5455/njppp.2023.13.08381202316082023 APA (American Psychological Association) Style M, K. T., N, . V. N., R, . S., Kumar, . A. & S, . U. M. (2024) Neutrophil–lymphocyte ratio as a diagnostic marker for predicting early-stage diabetic nephropathy in patients attending a tertiary health-care center. National Journal of Physiology, Pharmacy and Pharmacology, 14 (3), 473-479. doi:10.5455/njppp.2023.13.08381202316082023 |
